NCT03334812 Study on Safety, Tolerability and Prelimenary Efficacy of LNA043 in Patients Undergoing Autologous Chondrocyte Implantation Status TERMINATED Phase PHASE2
NCT03334747 Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria. Status COMPLETED Phase PHASE2
NCT03333694 Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis) Status TERMINATED Phase PHASE1
NCT03333343 Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03333109 Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients Status COMPLETED Phase PHASE3
NCT03328897 Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria Status COMPLETED Phase PHASE3
NCT03320941 A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity Status COMPLETED Phase PHASE2
NCT03312738 A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor Status COMPLETED Phase PHASE2
NCT03301896 Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT03300427 The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients Status COMPLETED Phase PHASE4
NCT03299686 Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma Status COMPLETED Phase PHASE2
NCT03297294 Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN) Status TERMINATED Phase PHASE2
NCT03287414 Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT03285607 MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer Status WITHDRAWN Phase PHASE1
NCT03284242 A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients Status COMPLETED Phase EARLY_PHASE1
NCT03280030 A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML Status COMPLETED Phase PHASE2
NCT03275064 Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis. Status COMPLETED Phase PHASE2
NCT03264989 Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) Status COMPLETED Phase PHASE2
NCT03259074 Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) Status COMPLETED Phase PHASE3